[25] STING agonists have been shown to enhance antibody‐dependent CTL responses to influenza vaccines, highlighting the advantages of the STING pathway in mediating FcR functions.[53] Relative to rSC0119(pS‐SaoAACA−), rSC0120(pS‐SaoAACA−) induced OPA antibodies against homologous SS2 as well as heterologous serotypes SS7, SS9, and SS1/2 (Figure 6D,E). The gene discussed is STING1; the disease is influenza.